In this issue:
Etrasimod as induction and maintenance for UC
Low-dose thioguanine for IBD with intolerance to conventional thiopurines
1-kestose in mild-to-moderate UC
Golimumab intensification in UC
Cost effectiveness of adjuvant recombinant zoster vaccine in IBD
Increased proportion of CRC in patients with UC undergoing surgery
Sulconazole nanocrystals prevent fibrosis and stricture formation
Dose intensification alters infliximab pharmacokinetics but not clinical response
MSCs for refractory ileal-anal anastomosis and peripouch fistulae
UPF intake increases CD but not UC risk
Please login below to download this issue (PDF)